HER2 Support Group Forums - View Single Post - (MUC1 agonist to reverse multiple resistances) MUC1* is a determinant of trastuzumab

Hopeful · 05-08-2009, 06:27 AM

The stat is meaningless unless we know what it represents - is this 35% of ALL Her2+ patients, both metastatic and early stage bc? Stats that lump those two groups together are not useful.

Hopeful

05-08-2009, 06:27 AM	#6
Hopeful Senior Member Join Date: Aug 2006 Posts: 3,380	The stat is meaningless unless we know what it represents - is this 35% of ALL Her2+ patients, both metastatic and early stage bc? Stats that lump those two groups together are not useful. Hopeful